“…A previous study found that LMNA (lamin A/C) [85], SLC11A2 [163], CRTC2 [164], TBK1 [165], GRN (granulin precursor) [166], CTSD (cathepsin D) [167], STARD10 [168], PGRMC1 [169], TFE3 [170], POR (cytochrome p450 oxidoreductase) [171], SESN1 [172], IL15 [173], PIK3R1 [134], OSM (oncostatin M) [98], SOCS3 [174], USP21 [100], GLUL (glutamate-ammonia ligase) [175], IL1R1 [176], TP53 [177], PPM1A [178], CTBP1 [179], DNAJC3 [180], ATP6 [181], DDX21 [182], COX2 [183], RACK1 [184], ND1 [158], CCND2 [185] and COX1 [186] are positively correlated with type 2 diabetes mellitus, suggesting its potential as a biomarker for type 2 diabetes mellitus. LMNA (lamin A/C) [187], PFKFB3 [188], TRAF2 [189], ADORA2B [190], ACADS (acyl-CoA dehydrogenase short chain) [191], IRF7 [192], ASL (argininosuccinatelyase) [193], IL15 [194], PIK3R1 [195], OSM (oncostatin M) [196], SOCS3 [197], CHD9 [198], IFI44L [199], GNLY (granulysin) [200], FLNB (filamin B) [201], IL1R1 [202], SETD3 [203], TP53 [204], BRD4 [205], COX2 [206], HSP90AB1 [207], SLC7A1 [208], ND2 [209] and COX1 [210] have been reported to be associated with hypertension. LMNA (lamin A/C) [211], INPP5K [212], SCYL1 [213], AKR7A2 [214], TRAF2 [215], SLC11A2 [216], NEU1 [217], SNAP29 [218], DUSP22 [219], P2RX4 [220], ADORA2B [221], NAXD (NAD(P)HX dehydratase) [222], FEZ1 [223], TBK1 [224], GRN (granulin precursor) [225], ATG4D [226], CTSD (cathepsin D) [227], PPP2R5D […”